TipRanks
Advertisement
Advertisement

OSTX Stock Latest News

Herlystic’s Strong Phase 2b Survival Data and Advancing Regulatory Milestones Support Unchanged $6 Price Target and Buy Rating on OSTX
RatingsHerlystic’s Strong Phase 2b Survival Data and Advancing Regulatory Milestones Support Unchanged $6 Price Target and Buy Rating on OSTX
54m ago
OSTX
OS Therapies bolsters leadership team amid commercialization push
PremiumCompany Announcements
OS Therapies bolsters leadership team amid commercialization push
2d ago
8K
OSTX
OS Therapies: Regulatory Momentum for Herlystic Supports Continued Buy Rating with Unchanged $6 Price Target
PremiumRatings
OS Therapies: Regulatory Momentum for Herlystic Supports Continued Buy Rating with Unchanged $6 Price Target
12d ago
OSTX
OS Therapies announces full alignment on UK authorization application
PremiumThe Fly
OS Therapies announces full alignment on UK authorization application
22d ago
OSTX
OS Therapies Announces Prospectus for Secondary Share Resales
PremiumCompany Announcements
OS Therapies Announces Prospectus for Secondary Share Resales
27d ago
8K
OSTX
OS Therapies Stockholders Approve Incentive Plan and Board
PremiumCompany AnnouncementsOS Therapies Stockholders Approve Incentive Plan and Board
28d ago
8K
OSTX
Jason McCarthy Initiates Buy on OS Therapies, Citing Advancing OST-HER2 Program, Key Regulatory Catalysts, and Strengthened Cash Runway Into 2027
Premium
Ratings
Jason McCarthy Initiates Buy on OS Therapies, Citing Advancing OST-HER2 Program, Key Regulatory Catalysts, and Strengthened Cash Runway Into 2027
1M ago
OSTX
OS Therapies Launches $75 Million At-The-Market Offering
Premium
Company Announcements
OS Therapies Launches $75 Million At-The-Market Offering
2M ago
8K
OSTX
OS Therapies Announces Convertible Note Financing and Warrants
PremiumCompany Announcements
OS Therapies Announces Convertible Note Financing and Warrants
2M ago
8K
OSTX
OS Therapies Settles Leonite Debt, Issues Bridge Financing
PremiumCompany Announcements
OS Therapies Settles Leonite Debt, Issues Bridge Financing
2M ago
8K
OSTX
OS Therapies Ends At-The-Market Equity Sales Program
PremiumCompany Announcements
OS Therapies Ends At-The-Market Equity Sales Program
2M ago
8K
OSTX
OS Therapies terminates At Market Issuance Sales Agreement
PremiumThe Fly
OS Therapies terminates At Market Issuance Sales Agreement
2M ago
OSTX
OS Therapies initiated with a Buy at Roth Capital
PremiumThe FlyOS Therapies initiated with a Buy at Roth Capital
3M ago
OSTX
OS Therapies Secures Convertible Note Financing for Expansion
Premium
Company Announcements
OS Therapies Secures Convertible Note Financing for Expansion
3M ago
8K
OSTX
OS Therapies price target lowered to $13 from $14 at Lake Street
Premium
The Fly
OS Therapies price target lowered to $13 from $14 at Lake Street
5M ago
OSTX
OS Therapies Delays Quarterly SEC Filing
PremiumCompany Announcements
OS Therapies Delays Quarterly SEC Filing
5M ago
OSTX
OS Therapies Gains EMA Rolling Review for OST-HER2
PremiumCompany Announcements
OS Therapies Gains EMA Rolling Review for OST-HER2
5M ago
8K
OSTX
OSTX Earnings this Week: How Will it Perform?
PremiumPre-Earnings
OSTX Earnings this Week: How Will it Perform?
6M ago
OSTX
OS Therapies bolsters funding to advance OST-HER2 program
PremiumCompany Announcements
OS Therapies bolsters funding to advance OST-HER2 program
6M ago
8K
OSTX
Regulatory Momentum and De-Risked Path to Accelerated Approval Support Buy Rating on OST-HER2 Osteosarcoma Program
PremiumRatingsRegulatory Momentum and De-Risked Path to Accelerated Approval Support Buy Rating on OST-HER2 Osteosarcoma Program
6M ago
OSTX
OS Therapies price target lowered to $14 from $17 at Lake Street
Premium
The Fly
OS Therapies price target lowered to $14 from $17 at Lake Street
6M ago
OSTX
OS Therapies Files Prospectus Supplement for Share Resale
Premium
Company Announcements
OS Therapies Files Prospectus Supplement for Share Resale
6M ago
8K
OSTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >